Protagonist Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Protagonist Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Protagonist Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Protagonist Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $17M | 252k | 66.43 |
| 2025-03-31 | $23M | 469k | 48.36 |
| 2024-12-31 | $22M | 577k | 38.60 |
| 2024-09-30 | $23M | 503k | 45.00 |
| 2024-06-30 | $13M | 377k | 34.65 |
| 2024-03-31 | $6.9M | 237k | 28.93 |
| 2023-12-31 | $9.4M | 411k | 22.93 |
| 2023-09-30 | $3.9M | 232k | 16.68 |
| 2023-06-30 | $7.3M | 265k | 27.62 |
| 2023-03-31 | $1.6M | 71k | 23.00 |
| 2022-12-31 | $3.3M | 303k | 11.04 |
| 2022-06-30 | $957k | 121k | 7.94 |
| 2022-03-31 | $1.6M | 69k | 23.68 |
| 2021-12-31 | $15M | 437k | 34.20 |
| 2021-03-31 | $15M | 585k | 25.90 |
| 2020-12-31 | $14M | 703k | 20.16 |
| 2020-09-30 | $16M | 785k | 20.25 |
| 2020-06-30 | $15M | 838k | 17.66 |
| 2020-03-31 | $6.2M | 883k | 7.06 |
| 2019-12-31 | $1.8M | 259k | 7.05 |
| 2019-09-30 | $3.4M | 282k | 12.03 |
| 2019-06-30 | $6.7M | 559k | 11.98 |
| 2019-03-31 | $3.5M | 281k | 12.57 |
| 2018-12-31 | $1.1M | 164k | 6.73 |
| 2018-09-30 | $2.5M | 241k | 10.29 |
| 2018-06-30 | $461k | 69k | 6.72 |
| 2018-03-31 | $20k | 2.3k | 8.71 |
| 2017-12-31 | $4.3M | 205k | 20.80 |
| 2017-06-30 | $96k | 8.5k | 11.34 |
| 2017-03-31 | $118k | 9.2k | 12.83 |
| 2016-12-31 | $233k | 11k | 21.96 |
| 2016-09-30 | $45k | 2.1k | 21.35 |